Epithalon Research for Anti-Aging
An evidence-based overview of research examining Epithalon in the context of anti-aging. This page synthesizes findings from peer-reviewed literature.
Research Summary
Epithalon is marketed primarily for anti-aging based on claimed telomerase activation and lifespan extension in animal models. Russian research reports 31-44% lifespan increases in mice and extended cellular replicative capacity. A 2025 independent UK study confirmed telomerase activation in human fibroblasts in vitro. No controlled human clinical trials have evaluated anti-aging outcomes.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Anti-Aging
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Epithalon has not received regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.